Acknowledgement
We thank the National Research Foundation of Korea for supporting our project.
References
- Abbott A. 2003. Cell culture: biology's new dimension. Nature 424:870-872. https://doi.org/10.1038/424870a
- Arrondeau J, Gan HK, Razak AR, Paoletti X, Le Tourneau C. 2010. Development of anti-cancer drugs. Discov. Med. 10:355-362.
- Bhadriraju K and Chen CS. 2002. Engineering cellular microenvironments to improve cell-based drug testing. Drug Discov. Today 7:612-620. https://doi.org/10.1016/S1359-6446(02)02273-0
- Bodey B, Bodey B Jr, Siegel SE, Kaiser HE. 2000. Immunocytochemical detection of MMP-3 and -10 expression in hepatocellular carcinomas. Anticancer Res. 20(6B):4585-4590.
- Cukierman E, Pankov R, Yamada KM. 2002. Cell interactions with three-dimensional matrices. Curr. Opin. Cell Biol. 14:633-639. https://doi.org/10.1016/S0955-0674(02)00364-2
- Elkington PT, Green JA, Friedland JS. 2009. Analysis of matrix metalloproteinase secretion by macrophages. Methods Mol. Biol. 531:253-265. https://doi.org/10.1007/978-1-59745-396-7_16
- Friedrich J, Ebner R, Kunz-Schughart LA. 2007. Experimental anti-tumor therapy in 3-D: spheroids--old hat or new challenge? Int. J. Radiat. Biol. 83:849-871. https://doi.org/10.1080/09553000701727531
- Lim M, Kim Y, Shin Y, Oh KB, Hwang S, Kim Y, Hur TY, Ock SA. 2016. Evaluation of primary hepatocyte function using 2D or 3D culture method for primary rat hepatocytes. J. Emb. Trans. 31:169-177. https://doi.org/10.12750/JET.2016.31.3.169
- Monvoisin A, Bisson C, Si-Tayeb K, Balabaud C, Desmouliere A, Rosenbaum J. 2002. Involvement of matrix metalloproteinase type-3 in hepatocyte growth factor-induced invasion of human hepatocellular carcinoma cells. Int. J. Cancer 97:157-162. https://doi.org/10.1002/ijc.1595
- Naim A, Pan Q, Baig MS. 2017. Matrix metalloproteinases (MMPs) in liver diseases. J. Clin. Exp. Hepatol. 7:367-372. https://doi.org/10.1016/j.jceh.2017.09.004
- Snoek-van Beurden PA and Von den Hoff JW. 2005. Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors. Biotechniques 38:73-83. https://doi.org/10.2144/05381RV01
- Sternlicht MD, Bissell MJ, Werb Z. 2000. The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter. Oncogene 19:1102-1113. https://doi.org/10.1038/sj/onc/1203347
- Tandara AA and Mustoe TA. 2011. MMP- and TIMP-secretion by human cutaneous keratinocytes and fibroblasts--impact of coculture and hydration. J. Plast. Reconstr. Aesthet. Surg. 64:108-116. https://doi.org/10.1016/j.bjps.2010.03.051
- Winer A, Adams S, Mignatti P. 2018. Matrix metalloproteinase inhibitors in cancer therapy: turning past failures into future successes. Mol. Cancer Ther. 17:1147-1155. https://doi.org/10.1158/1535-7163.MCT-17-0646
- Yun JI, Kim MS, Lee ST. 2013. Effects of extracellular stimulation of different niche condition on the transcriptional regulation of matrix metalloproteinase genes in the mouse embryonic stem cells. Reprod. Dev. Biol. 37:79-83. https://doi.org/10.12749/RDB.2013.37.2.79